Roche Signs Deal to Expand Access to Flu Drug Xofluza
Roche and the Medicines Patent Pool signed a deal to license the flu drug Xofluza across 129 countries. Generic makers will produce the pill to boost supply.
Xurve View
Insights:
Xurve View
ROCHE HOLDING AG-BR signed a licensing deal with the Medicines Patent Pool to expand Xofluza access across 129 countries. The agreement allows generic manufacturers to produce the antiviral pill for low- and middle-income markets. This move secures manufacturing capacity and supply channels ahead of seasonal outbreaks or future pandemics.
